AlloVir Gains Third RMAT Designation For Antiviral T Cell Therapy

Could Help Prevent Infection In 40,000 Patients

 
• By Andrew McConaghie

Gaining the special regulatory status in a prophylactic setting for posoleucel is the most significant yet for the T cell therapy developer.

Cell Separator
A cell separator collects stem cells for use in an allogenic hematopoietic stem cell transplant. • Source: Alamy

More from Anti-infective

More from Therapy Areas